Navigation Links
Statins could ease coughing in lung disease patients, study finds
Date:3/24/2014

Common cholesterol-lowering drugs could provide relief to patients suffering from a chronic lung disease, a study has shown.

The drugs known as statins were found to help alleviate the chronic coughing associated with the disease for some patients.

Statins are commonly prescribed for people at risk of heart attack because they can reduce cholesterol levels, but scientists are increasingly finding that they also have anti-inflammatory effects.

Researchers at the University of Edinburgh have shown the therapeutic potential of statins to treat patients with an inflammatory lung condition known as bronchiectasis.

Bronchiectasis is a disabling disease affecting one in 1000 British adults that is associated with a vicious cycle of bacterial infection and inflammation in the lungs and airways. It can be life-threatening and it leaves patients with daily symptoms that include chronic coughing, excessive phlegm production and repeated chest infections.

The team found that a daily high dose of statins over six months led to significant improvement in coughing symptoms for 12 out of the 30 patients treated in the study.

After six months of taking statins, patients could better tolerate gentle exercise and walk further than they could before treatment. They also had fewer flare ups of disease and less inflammation in their airways.

Six patients stopped taking the statins before the end of the study because of side effects such as headaches. However, there were no serious side effects from the treatment.

The findings suggest that statins could offer an alternative to long-term antibiotic treatment, which raises patients' risk of infection from antibiotic resistant strains of bacteria such as MRSA or C. difficile.

For most patients the causes of bronchiectasis are not known but it has been linked to serious lung infections in childhood, such as whooping cough or pneumonia, which damage the airways.

Dr Pallavi Mandal, a Clinical Research Fellow at the University of Edinburgh who led the study, said: "There are few effective treatments for bronchiectasis so these are encouraging findings. Larger studies are now needed to find out whether statins could be useful as a long-term treatment option for patients with this disease."


'/>"/>

Contact: Jen Middleton
jen.middleton@ed.ac.uk
44-131-650-6514
University of Edinburgh
Source:Eurekalert

Related medicine news :

1. High potency statins linked to better outcome following a heart attack
2. Could statins be used to fight a deadly viral infection?
3. As Lipitor Lawsuits Mount, Bernstein Liebhard LLP Notes Publication of New Study with Possible Explanation for Link between Statins and Diabetes
4. Cleveland Clinic research: Most statin-intolerant patients can eventually tolerate statins
5. High dose statins prevent dementia
6. Statins reduce CV events in CAD patients with very low LDL-C
7. Statins prevent cataracts
8. Specialized treatment helps cholesterol patients who suffer side effects from statins
9. Could Statins Raise Diabetes Risk?
10. Statins May Hamper Workout Results
11. Zocor Side Effects Update: Bernstein Liebhard LLP Comments on New Study Linking Kidney Problems to High Doses of Zocor, Other Statins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... 2017 , ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues”: ... SPIRITUAL COMPASS To Navigate Life Issues” is the creation of published author, Rachel Jamerson, ... of Directors for CONTACT USA, and former member of the American Association of Christian ...
(Date:4/24/2017)... Miami, FL (PRWEB) , ... April 24, 2017 ... ... John Paul Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s ... 4-6, 2017. , The Oral Reconstruction Foundation will present its annual Global Symposium ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... work wear distributors and International relief organizations across the globe to provide effective ... offers lifestyle and work wear collections via insectshield.com . In the wake ...
(Date:4/24/2017)... ... April 24, 2017 , ... A 2-in-1 ... the same place. From 101 Water Texas, here are the ways in which ... enjoy a continuous supply of pure, fresh, oxygenated water, with both cold and ...
(Date:4/23/2017)... ... April 23, 2017 , ... ... announced the achievement of Cisco Select certification and SMB specialization. Altura is ... , In earning the Select Certification, Altura fulfilled the training and ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... and Gynecology markets with innovative and proprietary products, will ... 31, 2017 after the market close on Tuesday, May ... a conference call and webcast to discuss its financial ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 /PRNewswire/ ... ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron Ehlen ... the signing of a three-year exclusive sales representation ... a dedicated sales team to introduce Imprimis, ophthalmic ... focused in 13 states in the U.S. Midwest. Precision ...
(Date:4/18/2017)... , April 18, 2017 Recursion Pharmaceuticals ... science with machine learning techniques to discover treatments for ... Yolanda Chong as vice president of biology. ... & Johnson in Belgium , where ... focused on applying high-dimensional biological approaches to the small ...
Breaking Medicine Technology: